AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
23.39
-0.43 (-1.81%)
At close: Jun 18, 2025, 4:00 PM
23.50
+0.11 (0.47%)
After-hours: Jun 18, 2025, 5:26 PM EDT
AnaptysBio Stock Forecast
Stock Price Forecast
The 10 analysts that cover AnaptysBio stock have a consensus rating of "Buy" and an average price target of $44.25, which forecasts a 89.18% increase in the stock price over the next year. The lowest target is $20 and the highest is $90.
Price Target: $44.25 (+89.18%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 1 | 1 | 1 | 2 |
Buy | 5 | 6 | 5 | 5 | 5 | 5 |
Hold | 4 | 4 | 4 | 4 | 4 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 12 | 10 | 10 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $22 → $38 | Hold → Strong Buy | Upgrades | $22 → $38 | +62.46% | Jun 4, 2025 |
Guggenheim | Guggenheim | Strong Buy Maintains $54 → $90 | Strong Buy | Maintains | $54 → $90 | +284.78% | May 28, 2025 |
Guggenheim | Guggenheim | Strong Buy Maintains $52 → $54 | Strong Buy | Maintains | $52 → $54 | +130.87% | May 6, 2025 |
Wedbush | Wedbush | Buy Reiterates $40 | Buy | Reiterates | $40 | +71.01% | May 1, 2025 |
JP Morgan | JP Morgan | Buy Maintains $36 → $42 | Buy | Maintains | $36 → $42 | +79.56% | Mar 5, 2025 |
Financial Forecast
Revenue This Year
66.99M
from 91.28M
Decreased by -26.61%
Revenue Next Year
83.32M
from 66.99M
Increased by 24.39%
EPS This Year
-5.41
from -5.12
EPS Next Year
-5.06
from -5.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 149.7M | 216.3M | 155.9M | ||
Avg | 67.0M | 83.3M | 82.3M | ||
Low | 27.2M | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 64.0% | 222.9% | 87.0% | ||
Avg | -26.6% | 24.4% | -1.3% | ||
Low | -70.2% | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -3.09 | -1.56 | -3.02 | ||
Avg | -5.41 | -5.06 | -5.58 | ||
Low | -6.88 | -6.76 | -9.76 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.